GGrantIndex
Sort

39,280 grants matching leukemia

Targeting Novel Pathways in JMML

$534,541
Reuben Kapur · Indiana University Indianapolis · R01 · FY2019 · HL

Protein-coding and non-coding RNA biomarkers for early detection of CLL

$534,489
George A. Calin · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA

Digital PCR quantification of BCR-ABL for CML diagnosis and monitoring in a LMICs setting

$534,320
Daniel T Chiu · University Of Washington · UG3 · FY2017 · CA

Gene Therapy for Canine X-linked SCID

$534,319
University Of Pennsylvania · R01 · FY2004 · AI

T-Cell Targeting for GVHD

$534,296
Bruce R. Blazar · University Of Minnesota · R01 · FY2020 · HL

Analysis of Nematode Sex Determination

$534,268
Barbara J Meyer · University Of California Berkeley · R01 · FY2012 · GM

The Brooklyn Minority-Based Community Clinical Oncology Program

$534,190
William Barney Solomon · Suny Downstate Medical Center · U10 · FY2010 · CA

Novel combination therapy for AML expressing mutant RUNX1

$534,187
Courtney Dinardo · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA

Project 1. Regulation of Mast Cell Homeostasis in Type 2 Immunopathology

$534,112
Joshua A Boyce · Brigham And Women'S Hospital · U19 · FY2023 · AI

Targeted Therapy for Lymphoid Malignancies

$534,094
John C Byrd · Ohio State University · R01 · FY2013 · CA

Targeted Radiotherapy of Neoplastic Meningitis using Monoclonal Antibodies Label

$534,032
Michael Rod Zalutsky · Duke University · P01 · FY2016 · CA

Genetic Dissection of Drosophila Hematopoiesis

$534,021
Utpal Banerjee · University Of California Los Angeles · R01 · FY2009 · HL

Effect of inflammation on JAK2 mutant evolution in the hematopoietic system: mathematical models and experiments

$533,981
Angela Goffredo Fleischman · University Of California-Irvine · R37 · FY2023 · CA

T-Cell Targeting for GVHD

$533,936
Bruce R. Blazar · University Of Minnesota · R01 · FY2021 · HL

Preventing Fatal Infections in Children with Down Syndrome During Treatment for Acute Lymphoblastic Leukemia

$533,887
Sandra W Ryeom · Columbia University Health Sciences · R01 · FY2025 · CA

Mechanistic and translational studies of CBF leukemia

$533,882
Paul Liu · National Human Genome Research Institute · ZIA · FY2025 · HG

A Mouse Model of DNMT3A-Associated Hematologic Malignancy

$533,845
Margaret Goodell · Baylor College Of Medicine · R01 · FY2018 · CA

A Mouse Model of DNMT3A-Associated Hematologic Malignancy

$533,845
Margaret Goodell · Baylor College Of Medicine · R01 · FY2017 · CA

Endocrine-immune-reproductive System Interactions

$533,831
Tomoshige Kino · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2011 · HD

Mechanisms of T-cell leukemogenesis induced by NOTCH1

$533,649
Adolfo A. Ferrando · Columbia University Health Sciences · R01 · FY2009 · CA

Molecular Genetics

$533,439
Carlo M Croce · University Of California, San Diego · P01 · FY2015 · CA

Assessing Metabolically Reprogrammed and Purified CD19-CAR-T in NHL and CLL

$533,348
Brian Hess · Medical University Of South Carolina · R01 · FY2024 · CA

DNMT3A in Development of Hematologic Malignancies

$533,242
Margaret Goodell · Baylor College Of Medicine · R01 · FY2019 · CA

DNMT3A in Development of Hematologic Malignancies

$533,242
Margaret Goodell · Baylor College Of Medicine · R01 · FY2021 · CA

UG1 - NCTN (Network Lead)

$533,194
Hedy L Kindler · University Of Chicago · UG1 · FY2022 · CA